๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Soy, isoflavones, and prostate cancer

โœ Scribed by Le Jian

Book ID
102510922
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
449 KB
Volume
53
Category
Article
ISSN
1613-4125

No coin nor oath required. For personal study only.

โœฆ Synopsis

Abstract

Prostate cancer has marked geographic variations between countries. Genetic, epigenetic, and environmental factors coโ€contribute to the development of the cancer. The association between dietary factors and prostate cancer has been investigated and one explanation for the low incidence of the cancer in Asia might be high consumption of fresh vegetables including soybean and its products. Soybean is a species of legume contain high amount of isoflavones including genistein, daidzein, glycitein, and equol, which have a prophylactic effect on prostate cancer. In this article, epidemiological and laboratory studies on the relationship between soybeans, isoflavones and prostate cancer are reviewed and large scale multiethnic epidemiological studies are recommended.

๐Ÿ“œ SIMILAR VOLUMES

Soy isoflavones enhance radiotherapy in
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model
โœ Julian J. Raffoul; Sanjeev Banerjee; Mingxin Che; Zvi E. Knoll; Daniel R. Doerge ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 738 KB

## Abstract We previously reported that genistein, the bioactive isoflavone of soybeans, acts as a radiosensitizer for prostate cancer. Pretreatment of tumor cells with genistein potentiated radiationโ€induced killing __in vitro__ and in orthotopic models __in vivo__. However, pure genistein promote

Inhibition of prostaglandin synthesis an
Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients
โœ Srilatha Swami; Aruna V. Krishnan; Jacqueline Moreno; Rumi S. Bhattacharyya; Chr ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 513 KB

## Abstract Soy and its constituent isoflavone genistein inhibit the development and progression of prostate cancer (PCa). Our study in both cultured cells and PCa patients reveals a novel pathway for the actions of genistein, namely the inhibition of the synthesis and biological actions of prostag